Acuity Pharmaceuticals' Series B Round

Acuity Pharmaceuticals raised a round of funding on October 19, 2004.

OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed…

Articles about Acuity Pharmaceuticals' Series B Round: